Select a community
All Communities
Home > Community Treatment Reports > Metamucil Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Metamucil Treatment Report

See also: Metamucil Wafers

What is Metamucil? Metamucil® is a brand name for psyllium, an antidiarrheal laxative. It is used as a dietary fiber supplement; for the treatment of occasional constipation; and to reduce risk of coronary heart disease. Off label it is used for irritable bowel syndrome and inflammatory bowel disease.

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

43 patients in the community are taking or have taken Metamucil.

Dosages

Based on the patients currently taking Metamucil.

Top 10 (Show all)

All (Show top 10)

  1tps. as needed 3.4g/5.2g as needed 5 500mg as needed daily 1 tps. daily 2 mg daily 2 tbs. daily 2 tps. daily 3 tps. daily 3.4 g/11 g daily 3.4 g/5.2 g daily 3.4 g/7 g daily 3.4 g daily 5 tps. daily 10 other daily 500 mg daily 1000 mg daily 1500 mg daily 2500 mg daily 3000 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2 5 Number of Patients: 5 2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2  

Duration

How long current patients have been taking Metamucil or how long patients were taking Metamucil before stopping.

Currently Taking Metamucil

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
1
6
6
10

Stopped Taking Metamucil

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
3
0
1
0
3
Why Patients Stopped Taking Metamucil (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 3 38% Did not seem to work: 38%
Other 3 38% Other: 38%
Doctor's advice 1 13% Doctor's advice: 13%
Course of treatment ended 1 13% Course of treatment ended: 13%

Patient Reported Evaluations

Results from 3 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Can't tell 100% 1

General health

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 33% 1
None 67% 2

Top reported side-effects include:

Summary results are based on 3 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 3)

  • expastrychef
    Sex: M
    Sensation: Moderate
    Overall: Mild
    Cognition: moderate
    Vision: none
    Speech: none
    Swallowing: mild
    Upper limb: moderate
    Walking: moderate
  • expastrychef
  • by expastrychef
    Mar 14, 2009
  • EfficacyModerate
  • Side-effectsNone
  • Bowel problems

See all evaluation results for Metamucil

Report created on November 08, 2009.